Edesa Biotech (EDSA) Work In Process (2015)
Edesa Biotech (EDSA) posted Work In Process of $137021.0 for Q3 2015, up 69.75% sequentially from $80720.0 in Q2 2015.
Edesa Biotech (EDSA) Work In Process (2015) Analysis & Trends
Edesa Biotech has reported Work In Process for 1 years, with the latest figure at $137021.0 in Q3 2015.
- Quarterly Work In Process changed N/A year-over-year to $137021.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $137021.0 (changed N/A YoY) and the FY2015 annual result came in at $137021.0, changed N/A from the prior year.
- Work In Process improved to $137021.0 in Q3 2015 per EDSA's latest filing, from $80720.0 in the prior quarter.
- Over five years, Work In Process peaked at $137021.0 in Q3 2015 and troughed at $80720.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Edesa Biotech | 43.15 Mn | 43.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 137,021.00 |
| Jun 30, 2015 | 80,720.00 |